Category History

NOW

Gaia Healthcare has successfully registered over 30 pharmaceutical and generic products in the UAE, reflecting its commitment to quality and local healthcare needs. Now entering an exciting expansion phase across the GCC and West Africa, Gaia aims to broaden its…

2024

GAIA, introduced KETO-OME—a dual-action innovative formulation combining ketoprofen for pain and inflammation relief with omeprazole for gastric protection. Developed to minimize gastrointestinal side effects commonly linked to NSAIDs, KETO-OME progressed through formulation, regulatory approval, and branding, leading to its successful…

2023

GAIA, as the Marketing Authorization Holder (MAH), launched COMBIPLAX (Clopidogrel 75 mg + ASA 100 mg) following a structured timeline that began with product development, followed by regulatory submission and branding approval, leading to its successful market introduction.

2022

We have secured the local marketing authorization holder for innovative in-licensed pharmaceuticals, enabling us to provide healthcare professionals and patients with access to groundbreaking treatment options.

2020

GAIA Healthcare established the Sales & Marketing Division to build brand awareness, nurture client relationships, and broaden market penetration. It will focus on strategic sales initiatives and creative marketing campaigns to fortify GAIA Healthcare’s position in the healthcare sector.

2019

We have expanded our operations to a new state-of-the-art facility in Dubai Investment Park, enabling us to streamline operations and better serve customers.

2018

We have achieved 90% coverage of the UAE pharmaceutical market, solidifying our position as a trusted partner.

2017

PDC is a fast-growing business entity from the Gaia Healthcare Group focused on transforming traditional 3PL logistics services to reduce supply chain, logistics & warehousing practices and costs. They are on a path to become a significant player in the…

2016

To expand its reach and serve a larger population, Gaia Healthcare DMCC started and bought 12 pharmacy chains, which allowed it to have a significant impact on the healthcare landscape.